Methotrexate Injection
Product Images NDC 16729-277

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Methotrexate (NDC 16729-277). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Methotrexate Carton1

Carton label for Methotrexate Injection, USP 50 mg/2 mL (25 mg/mL) by Accord Healthcare, Inc. The single-use vial label shows the drug name, strength, NDC 16729-277-30, route for injection, and warnings including cytotoxic agent caution. Manufactured by Intas Pharmaceuticals, India. Storage instructions and preservative-free status are also noted.*

FDA Label Image

Methotrexate Carton2

Label for Methotrexate Injection USP, 250 mg/10 mL (25 mg/mL) in a 10 mL single-use vial. The label is for a cytotoxic agent, prescription only, and manufactured by Accord Healthcare, Inc. with manufacturing by Intas Pharmaceuticals. It includes storage instructions, vial content details, and warnings to see the package insert for full prescribing information.*

FDA Label Image

Methotrexate Carton3

The label for Methotrexate Injection, USP, 1 g/40 mL (25 mg/mL) by Accord Healthcare, Inc. The label states it is a cytotoxic agent, for prescription use only, and packaged as a single-use vial. It includes storage instructions, vial contents, and manufacturer details with barcode and NDC 16729-277-35.*

FDA Label Image

Methotrexate Label1

Label for Methotrexate Injection, USP 25 mg/mL (shown as 50 mg/2 mL) in a single-use vial. The label includes warnings such as CAUTION: Cytotoxic Agent and advises to see the package insert for full prescribing information. It is sterile and preservative free. The manufacturer is Accord Healthcare, Inc., Durham, NC, with manufacturing done by Intas Pharmaceuticals Limited, India. The NDC is 16729-277-30 for a 2 mL vial.*

FDA Label Image

Methotrexate Label2

Label for Methotrexate Injection USP 250 mg/10 mL (25 mg/mL), a sterile, preservative-free cytotoxic agent for injection by Accord Healthcare, Inc. The label includes dosage strength, dosage form, storage instructions, warnings, NDC 16729-277-03, single-use vial indication, and barcodes. Directions for full prescribing information and handling caution are also noted.*

FDA Label Image

Methotrexate Label3

Label for Methotrexate Injection, USP 1 g/40 mL (25 mg/mL) by Accord Healthcare, Inc. The label includes warnings about cytotoxicity and storage instructions, states the vial is single-use, preservative free, and lists sodium chloride and pH adjusters as inactive components. The label also provides NDC code 16729-277-35 and manufacturing details.*

FDA Label Image

Methotrexate Structure

Chemical structure of methotrexate showing its molecular arrangement of atoms and bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.